Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations

Abstract

Abstract This investigation facilitates a better understanding of inhibitor development, the critical treatment morbidity in HA patients. Furthermore, six novel mutations are reported, which would expand the mutation spectrum of the F8 gene.

Keywords

• factor VIII gene
• hemophilia A
• inhibitor risk